Your browser doesn't support javascript.
loading
Drug-Drug Interaction Potential with Once-Weekly Isoniazid/Rifapentine (3HP) for the Treatment of Latent Tuberculosis Infection.
Marzolini, Catia; Gibbons, Sara; van Oosterhout, Joep J; Khoo, Saye.
Afiliación
  • Marzolini C; Division of Infectious Diseases and Hospital Epidemiology, Departments of Medicine and Clinical Research, University Hospital of Basel, University of Basel, Petersgraben 4, 4031, Basel, Switzerland. catia.marzolini@usb.ch.
  • Gibbons S; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK. catia.marzolini@usb.ch.
  • van Oosterhout JJ; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Khoo S; Partners in Hope, Lilongwe, Malawi.
Clin Pharmacokinet ; 61(3): 339-346, 2022 03.
Article en En | MEDLINE | ID: mdl-34905153
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Latente / Isoniazida Límite: Humans Idioma: En Revista: Clin Pharmacokinet Año: 2022 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis Latente / Isoniazida Límite: Humans Idioma: En Revista: Clin Pharmacokinet Año: 2022 Tipo del documento: Article País de afiliación: Suiza